View in EDS

Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines.

Saved in:
Bibliographic Details
Title: Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines.
Authors: Lim JSJ; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore; Experimental Therapeutics Programme, Cancer Science Institute, Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University Singapore, Singapore., Ow SGW; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore., Wong ALA; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore; Experimental Therapeutics Programme, Cancer Science Institute, Singapore, Singapore., Lee MXW; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore., Chan GHJ; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore., Low JL; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore., Sundar R; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University Singapore, Singapore., Choo JRE; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore., Chong WQ; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore., Ang YLE; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore., Tai BC; Saw Swee Hock School of Public Health, National University Singapore, Singapore., Lee SC; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore; Experimental Therapeutics Programme, Cancer Science Institute, Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University Singapore, Singapore. Electronic address: csilsc@nus.edu.sg.
Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2023 Nov; Vol. 193, pp. 113311. Date of Electronic Publication: 2023 Aug 25.
Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study
Journal Info: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37717281
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lim+JSJ%22">Lim JSJ</searchLink>; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore; Experimental Therapeutics Programme, Cancer Science Institute, Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ow+SGW%22">Ow SGW</searchLink>; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Wong+ALA%22">Wong ALA</searchLink>; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore; Experimental Therapeutics Programme, Cancer Science Institute, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lee+MXW%22">Lee MXW</searchLink>; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chan+GHJ%22">Chan GHJ</searchLink>; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Low+JL%22">Low JL</searchLink>; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Sundar+R%22">Sundar R</searchLink>; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Choo+JRE%22">Choo JRE</searchLink>; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Chong+WQ%22">Chong WQ</searchLink>; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Ang+YLE%22">Ang YLE</searchLink>; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Tai+BC%22">Tai BC</searchLink>; Saw Swee Hock School of Public Health, National University Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lee+SC%22">Lee SC</searchLink>; Department of Hematology-Oncology, National University Cancer Institute, Singapore, Singapore; Experimental Therapeutics Programme, Cancer Science Institute, Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Medicine, National University Singapore, Singapore. Electronic address: csilsc@nus.edu.sg.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2023 Nov; Vol. 193, pp. 113311. <i>Date of Electronic Publication: </i>2023 Aug 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37717281
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejca.2023.113311
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 113311
    Titles:
      – TitleFull: Phase II study of trifluridine/tipiracil in metastatic breast cancers with or without prior exposure to fluoropyrimidines.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lim JSJ
      – PersonEntity:
          Name:
            NameFull: Ow SGW
      – PersonEntity:
          Name:
            NameFull: Wong ALA
      – PersonEntity:
          Name:
            NameFull: Lee MXW
      – PersonEntity:
          Name:
            NameFull: Chan GHJ
      – PersonEntity:
          Name:
            NameFull: Low JL
      – PersonEntity:
          Name:
            NameFull: Sundar R
      – PersonEntity:
          Name:
            NameFull: Choo JRE
      – PersonEntity:
          Name:
            NameFull: Chong WQ
      – PersonEntity:
          Name:
            NameFull: Ang YLE
      – PersonEntity:
          Name:
            NameFull: Tai BC
      – PersonEntity:
          Name:
            NameFull: Lee SC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2023 Nov
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0852
          Numbering:
            – Type: volume
              Value: 193
          Titles:
            – TitleFull: European journal of cancer (Oxford, England : 1990)
              Type: main
ResultId 1